3.82
3.78%
-0.15
Pre-mercato:
3.82
Absci Corp Borsa (ABSI) Ultime notizie
Monitoring Absci Corp (ABSI) after recent insider movements - Knox Daily
Market Update: Absci Corp (ABSI) Sees Negative Movement, Closing at 3.97 - The Dwinnex
There is no doubt that Absci Corp (ABSI) ticks all the boxes. - SETE News
Absci Co. (NASDAQ:ABSI) Short Interest Update - MarketBeat
Absci Co. (NASDAQ:ABSI) Short Interest Up 8.2% in September - Defense World
Deerfield Management Company L.P. Series C Purchases 135,652 Shares of Absci Co. (NASDAQ:ABSI) - MarketBeat
Taking the lead: Absci Corp (ABSI) - SETE News
CFO / CBO Jonasson Zachariah sale 19,859 shares of Absci Corp [ABSI] - Knox Daily
Was Absci Corp (ABSI)’s session last reading good? - US Post News
Market Insights: Absci Corp (ABSI)’s Notable Drop of -1.74, Closing at 3.96 - The Dwinnex
Absci Corp (ABSI) rating initates by Morgan Stanley - Knox Daily
Absci Co. (NASDAQ:ABSI) Shares Sold by Victory Capital Management Inc. - Defense World
Bank of New York Mellon Corp Boosts Holdings in Absci Co. (NASDAQ:ABSI) - MarketBeat
Navigating ABSI’s Stock Market Maze: Ups and Downs in 2023 - The InvestChronicle
Financial Metrics Exploration: Understanding Absci Corp (ABSI) Through Ratios - The Dwinnex
This trade activity should not be overlooked: Absci Corp (ABSI) - SETE News
Keeping an Eye on Absci Corp (ABSI) After Insider Trading Activity - Knox Daily
Absci Corp (ABSI) is a good investment, but the stock may be undervalued - US Post News
Absci Co. (NASDAQ:ABSI) Short Interest Up 8.1% in August - MarketBeat
Market Insight: Absci Corp (ABSI)’s Notable Gain, Closing at 3.69 - The Dwinnex
Views of Wall Street’s Leading Experts on Absci Corp - SETE News
ABSI’s 2023 Market Dance: Down -16.67% – Time to Invest? - The InvestChronicle
Is Absci Corp (ABSI) worth investing in despite its undervalued state? - US Post News
How does Absci Corp (ABSI) change from a tortoise to a hare? - SETE News
Absci Corp hits milestone in AstraZeneca AI drug collaboration - Investing.com
Absci Corp hits milestone in AstraZeneca AI drug collaboration By Investing.com - Investing.com Australia
Absci Corp (ABSI) may enjoy gains as insiders got busy in the recent days - Knox Daily
Quarterly Metrics: Quick and Current Ratios for Absci Corp (ABSI) - The Dwinnex
Hussman Strategic Advisors Inc. Makes New Investment in Absci Co. (NASDAQ:ABSI) - MarketBeat
Top 5 AI & Digital Biotech Companies (September 2024) - Securities.io
Absci Corporation (ABSI): A Penny Stock That Will Make You a Millionaire - Insider Monkey
Absci Corporation (ABSI): A Penny Stock That Will Make You a Millionaire - Yahoo Finance
Absci Corp (ABSI) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - The Motley Fool
Absci Corp [NASDAQ: ABSI] Sees Decrease in Stock Value - Knox Daily
Insider’s View: Deciphering Absci Corp (ABSI)’s Financial Health Through Ratios - The Dwinnex
11 Penny Stocks That Will Make You A Millionaire - Insider Monkey
ABSI stock rated an Overweight by Morgan Stanley - Knox Daily
Did Absci Corp (ABSI) perform well in the last session? - US Post News
Absci Co. (NASDAQ:ABSI) Shares Acquired by Sumitomo Mitsui Trust Holdings Inc. - Defense World
Sumitomo Mitsui Trust Holdings Inc. Has $2.25 Million Holdings in Absci Co. (NASDAQ:ABSI) - MarketBeat
Gaining Ground: Absci Corp (ABSI) Closes Higher at 4.23, Up 1.44 - The Dwinnex
Absci Corp (ABSI) expanding its growth trajectory ahead - SETE News
Absci to Participate in Upcoming Investor Conferences - Yahoo Finance
Absci Corporation (NASDAQ:ABSI) Q2 2024 Earnings Call Transcript - Insider Monkey
Absci Co. (NASDAQ:ABSI) Short Interest Down 10.0% in July - MarketBeat
Short Interest in Absci Co. (NASDAQ:ABSI) Decreases By 10.0% - Defense World
Absci (NASDAQ:ABSI) Rating Reiterated by HC Wainwright - Defense World
ABSI Shares Experience Surge in Value - Knox Daily
Absci stock retains Buy rating after analyst event By Investing.com - Investing.com Australia
Absci (NASDAQ:ABSI) Issues Earnings Results - Defense World
Absci CEO details Sloan Kettering Cancer Center partnership - Portland Business Journal
Absci Corp’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle
Absci (NASDAQ:ABSI) Rating Reiterated by HC Wainwright - MarketBeat
Absci stock retains Buy rating after analyst event - Investing.com India
Absci stock retains Buy rating after analyst event - Investing.com
Absci stock retains Buy rating after analyst event By Investing.com - Investing.com UK
Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results - wallstreet:online
Absci Corporation (ABSI) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Examining the Potential Price Growth of Absci Corp (ABSI) - Knox Daily
Holdings of Absci Corp (ABSI) are aligned with the stars - SETE News
Closing Strong: Absci Corp (ABSI) Ends at 3.69, Down -2.12 from Last Close - The Dwinnex
Generative AI vs. cancer: Absci partners with Memorial Sloan Kettering for new therapeutics - GeekWire
Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI - GlobeNewswire
Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI - Yahoo Finance
Absci Corp (ABSI) stock: A year of ups and downs - US Post News
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):